throbber

`
`PFIZER EX. 1115
`
`Page 1
`
`PFIZER EX. 1115
`Page 1
`
`

`

`
`
`PFIZER EX. 1115
`
`Page 2
`
`PFIZER EX. 1115
`Page 2
`
`

`

`
`
`PFIZER EX. 1115
`
`Page 3
`
`PFIZER EX. 1115
`Page 3
`
`

`

`
`
`PFIZER EX. 1115
`
`Page 4
`
`PFIZER EX. 1115
`Page 4
`
`

`

`
`
`PFIZER EX. 1115
`
`Page 5
`
`PFIZER EX. 1115
`Page 5
`
`

`

`Proc. Nat. Acad. Sci. USA
`Vol. 71, No. 9, pp. 3440-3444, September 1974
`
`The Three-Dimensional Structure of the Fab' Fragment of a Human
`Myeloma lmmunoglobulin at 2.0-A Resolution
`(/3-sheets/sequence alignments/hypervariable regions/active site)
`
`0
`
`R. J . POLJAK, L. M. AMZEL, B. L. CHEN, R. P. PHIZACKERLEY, AND F. SAUL
`
`Department of Biophysics, Johns Hopkins University School of Medicine, Baltimore, Maryland 21205
`
`Communicated by Max F. Perutz, June 14, 1974
`
`The structural analysis of the Fab' frag(cid:173)
`ABSTRACT
`ment of human mye)oma immunoglobulin lgGl(~) New
`has been extended to a nominal resolution of 2.0 A. Each
`of the structural subunits corresponding to the variable
`and to the constant homology regions of the light and
`heavy chains contains two irregular /3-sheets which are
`roughly paraJleJ to each other and surround a tightly
`packed interior of hydrophobic side chains. About 50-60%
`of the amino-acid residues are included in /3-p)eated
`sheets. Sequence alignments between the homology
`regions of Fab' New obtained by comparison of their
`three-dimensional structures are given. Some of the
`sequence variations observed in light and heavy chains and
`the role of the regions of hypervariable sequence in de(cid:173)
`fining the size and shape of the active site of different
`immunog)obulin molecules are discussed on the basis of
`the three-dimensional mode) of Fab' New.
`
`In a previous paper (2) we described the three-dimensional
`structure of the Fab' fragment of human myeloma immuno(cid:173)
`globulin IgG New based on the interpretation of an electron
`density map at 2.8-A resolution. The molecule was found to
`consist of four globular subunits which correspond to the
`variable (VL, VH) and constant (CL and CHl) homology regions
`of the light (L) and heavy (H) polypeptide chains, arranged
`in tetrahedral configuration. The homology subunits*, which
`closely resemble each other, share a basic pattern of poly(cid:173)
`peptide chain folding. This basic pattern (immunoglobulin
`fold) and an additional loop of polypeptide chain describe the
`more complex folding of the variable subunits. The additional
`loop in the VL subunit of IgG New is shortened by a deletion
`of seven amino acids which is unique to this L chain. The re(cid:173)
`gions of hypervariable sequence in the L and H chains were
`found to occur in close spatial proximity, at one end of the
`molecule. Two reports dealing with the three-dimensional
`structure of human immunoglobulin L chains have been
`published (3, 4). In this paper we extenlthe ~tructural analysis
`of Fab' New to a nominal resolution of 2.0 A and continue the
`description and discussion of its three-dimensional structure.
`
`METHODS
`Preliminary measurement of 13,000 x-ray reflections with
`spacings ranging from 2.8 to 2.0 A was carried out on native
`Fab' crystals. About 2000 of these reflections had intensities
`
`Abbreviations : The nomenclature of immunoglobulins, their
`chains and fragmen ts is as recommended by the World Healt h
`Organization ( 1) ; Dnp, 2,4-dinitrophenyl.
`* A homology subunit of an imniunoglobulin is defined as the
`globular unit of three-dimensional structure cont aining the
`amino-acid sequence of a homology region.
`
`significantly above background scattering and were selected
`for intensity measurements with techniques previously out(cid:173)
`lined (5). Procedures for the preparation of heavy atom de(cid:173)
`rivatives and phase determination have been previously given
`(5, 6). Three heavy atom compounds, phenylmercuric acetate,
`diacetoxymercury dipropylene dioxide and 1,4-diacetoxy(cid:173)
`mercuri-2,3-dimetoxybutane, were used to obtain isomorphous
`replacements to extend the pliase information from 2.8- to
`2.0-A resolution. The average figure of merit obtained for the
`2000 reflections with spacings between 2.8 and 2.0 A that
`were phased was 0.69. A 2.0-A resolution Fourier map was
`calculated including a total of 12,000 reflections with an
`average figure of merit of 0.76. Based on this map a model
`was constructed using an optical comparator (7) and Kendrew
`skeletal models.
`Purified Fab New was digested with CNBr and the resulting
`fragments were separated by gel filtration on Sephadex G-100
`columns. The amino-acid sequences of some of the tryptic and
`chymotryptic peptides of the CNBr fragments belonging to
`the VH region were determined by procedures previously out(cid:173)
`lined (8). These peptides were aligned by homology with ot?er
`human H chains, by sequence overlaps, and by information
`derived from the Fourier map.
`
`RESULTS AND DISCUSSION
`The 2.0-A m~p shows increased resolution with respect.~ th~
`previous 2.8-A Fourier map even though only 2000 add1tiona
`reflections were included. The amino-acid sequences of the
`
`CL, CHl, and VL regions and the tentative sequence of VH (A
`
`Fig. 1) correspond very closely to the features of the 2.0-
`Fourier map. The positions of most of the carbonyl gro~ps
`of the polypeptide chain can be easily identified in the e ec·
`tron density map. Careful placing of the carbonyl and a(cid:173)
`imino groups invariably maximized features of seco~da~
`b t
`n adiacen
`b d.
`structure such as hy rogen
`on mg
`e wee
`C 1
`d
`stretches of polypeptide chain. The VL, VH, CL, an~ ~
`homology subunits are predominantly folded in /3-P ea le
`sheet conformation. The CL homology subunit, for exarn~ed
`consists of a {:l-pleated sheet made up by four hydrogen-boll nd
`antiparallel chains (residues 116-120, 132-140, 160-169, :ti·
`173-182) and another {:l-pleated sheet containing three; see
`parallel chains (residues 147-151, 193- 199, and 202- 20 'sur·
`i.n(cid:173)
`Fig. 2). These two twisted and roughly parallel shee~s
`rou~d a tight~y packe? in~erior of hydroph~bic s_ide c~~;two
`their
`cludmg the mtracham disulfide bond which lmks
`sheets in a direction approximately perpendicular ~o the88
`planes. About 60% of the CL residues are included in
`
`3440
`
`PFIZER EX. 1115
`Page 6
`
`

`

`at. Acad. Sci. USA 71 (1974)
`
`Structure of Human Fab' at 2.0 A-Resolution
`
`3441
`
`50
`40
`30
`27 8 b C
`20
`10
`---ZSVLTQPPSVSGAP-GQRVTISCTGSSSNIGAGNHVKWYQQLPGTAPK-LLIFHNNA-
`w
`m
`10
`1
`~
`~
`~
`---ZVQLPESGPELVSP-GZTLSLTCTGSTVSTFAV-YIVWVRQPPGRGLEWIGYVFYHGTSDTDT
`
`150
`140
`130
`120
`110
`QPKAAPSVTLFPPSSEELQANKATLVCLISDFYPGAV-TVAWK--ADSS
`
`160
`150
`140
`130
`120
`ASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPV-TVSWN---SG--
`
`60
`-RFSVSKSG---
`
`90
`80
`70
`100
`109
`-SSATLAITGLQAEDEADYYCQSYDRS--LR-VFGGGTKLTVLR
`
`70
`-PLRSRVTHLVNT-S
`
`118
`llO
`100
`90
`80
`-KNQFSLRLSSVTAADTAVYYCARBLIAG-CIBVWGQGSLVTVSS
`
`214
`210
`200
`190
`180
`170
`160
`-PVKA- -GVETTTPS KQS NNKYAAS SYLS LTPEQWKS HKSYS CQVTH- -E GS T-VE KT-VAPTECS
`
`220
`210
`200
`190
`180
`170
`-ALTS--GVHTFPAVLQSSGLYSLSSVVTVPSSSLGT-QTYICNVNHKPSNTK-VDKR-VEPKSC
`
`Amino-acid sequences of the V1, CH, VH, and CHI homology regions of Fab New, aligned by comparison of their-three-di(cid:173)
`al structures (see text). Parts of the tentative VH sequence given here were obtained by Drs. Y. Nakashima and W. Konigsberg
`I communication). The Cal sequence is taken from ref. 9. Abbreviations are from ref. 10.
`
`leated sheets. The homologous subunits CHl, VL, and
`Figs. 2 and 3) can be described in similar terms. In
`n to the features of secondary structure just discussed,
`• ues 26-27 c appear in a helical conformation close to
`a r-helix (11) . Also, VL residues 78-82, and the ho(cid:173)
`us VH residues 87-91, fold with the conformation of a
`r or a-helix. In general, the precise conformation of
`id residues that do not belong to the regions of secon(cid:173)
`cture discussed above is more difficult to define,
`y when they correspond to regions of lower electron
`on the surface of the molecule.
`o-acid sequence comparisons have been extensively
`several laboratories to align the primary structures of
`
`different immunoglobulin molecules and their homology re(cid:173)
`gions. The alignment of VL and VH sequences with those of
`the CL and CH homology regions is less straightforward than
`alignments between VL and VH or between CL and CH regions.
`This problem can now be approached by matching their
`similar three dimensional structures and aligning residues
`that occupy an identical or similar position in the constant
`pattern of the tertiary structure of the homology subunits.
`Alignments obtained by this procedure, which is independent
`of amino-acid. sequence homologies, are shown in Fig. 1.
`Where homologies have been detected by sequence c0mpari(cid:173)
`son, it can be safely assumed that the three-dimensional
`structure of the homologous polypeptide chains will be very
`
`1
`2
`3
`-=~ M-U
`4
`68 ---24
`67
`,LJ, ::: 5
`'66 ::: 69
`~ ro=~
`1_ 102 --------------1..01
`6
`64 =n
`45
`86 ::: 35
`21
`12 ::: 20
`a __ ·103 ________________ ::::: as
`36 ::: 44
`63
`62 ::: 73
`19
`9
`:104
`84 ::: 37
`43
`2
`38 :::414
`61
`74 ::: 18
`10:· 105 ---------------------53
`60--75
`17
`
`93 92
`94 ::: 91
`95
`90 ---31
`98 ::: 89
`32
`99
`88 ::: 33
`
`12~ 26 27 27a 27b ~c 28 29 30 ~
`11 ::106 _J 39 40
`L6 -.:!: .. :g~
`
`4
`
`109
`
`r-~::=.--1
`
`76 77 78 79 80 81 82
`
`141 142 143 144 145 1461
`
`CL
`
`110
`Ill
`112
`171
`113
`170
`172
`114
`169---173
`115
`168
`174 ___ 140
`167:::175
`139:::116
`165166
`176:::138
`117
`j64 ___ 1 n m:::118
`163 178::~ 119
`162:::179
`135:::120
`161
`180:::134
`121
`160---151
`133
`122
`
`1s2l---m m
`
`126
`129
`128 127
`
`201 200
`202---199
`203
`198:::147
`~0045:::119976::=114489
`
`150
`206::~
`207
`194:::151
`205:::193
`152
`209
`192
`153
`
`fil J :J
`
`ru
`
`214
`
`183 184 185 186 187 188 189 190 191
`
`.._ __ __ ___ 159 158 157 156
`
`2627 2829 30 31 32~
`
`CH
`
`1 ~1511 s2 1s3154
`I m
`
`207 206
`208
`205
`209:::204
`
`- - - - - - - 16 5 164 - - - - - - - - -
`- - - - - - - 66 65 64 63 -
`61 60 59 - - - - - - -
`Diagram of the hydrogen bonds (broken lines) between main chain atoms for V1, C1, VH, and CHI. The hydrogen-bonded
`correspond to the two /j-sheets of each subunit (see text). Cysteine residues that participate in the intrachain disulfide bonds
`the two fj-sheets are enclosed in rectangles; C1 residue 213 and CHI residue 220 form the interchain disulfide bond and are also
`in rectangles. Numbers refer to residues as given in Fig. 1.
`
`l
`
`189 190 191 192 193 194 195 196 197
`
`102
`103
`101
`105104---100
`53 5'!. 55
`106 ··- 99 ::: 33
`52 ::_ 56
`W-~ ~=n"
`108
`97 ::: 35
`50 ::: 58
`109=1961
`36:::49
`48
`95 ::: 37
`110
`47
`111112 ::: 94
`38 ::: 46
`113
`93 ::: 39
`45
`114 ::: 92
`40
`44
`
`11 ::us J 41 42 43
`
`2
`25 --- 3
`7 5 76
`M n-H
`4
`73
`78
`23 ::: 5
`72
`79:::1221
`6
`'ff ::: 7
`71::: 80
`70
`81 ::: 20
`8
`69 ::: 82
`19
`9
`68
`83 ::: 18
`10,
`67 -84
`17
`12: 116
`85 --16
`'•15 •• 13 ··111
`18
`
`r----~
`86 ar;-;;~o ;1
`
`177
`150:::121
`176
`178
`149
`122
`175:::179
`174
`180---148
`123
`
`mg~===::~:::::~===:~1
`170---183
`.li2.===126
`169 184::~ 127
`16s:::1ss
`143:::12s
`167
`!86:::142
`129
`166---157
`141
`130
`188
`140
`131
`139
`132
`138
`133
`137
`134
`136 135
`
`216 J 161
`
`~:~:::~g~===:~~
`
`212 m===1s1
`
`158
`213::~
`214
`199---159
`215---195
`160
`
`162
`163
`
`217
`218
`219
`~
`
`PFIZER EX. 1115
`Page 7
`
`

`

`3442
`
`Immunology: Poljak et al.
`
`Proc. Nat. A cad. Sci. USA 71 (19'1.f)
`
`FIG. 3. Stereo pair drawing of the a-carbon backbone of the VH structure. Thin lines connect the a-carbon atoms of residues that are
`hydrogen-bonded; see Fig. 2. PCA is pyrrolidone carboxylic acid.
`
`similar. Since the amino-acid sequence of /3rmicroglobulin is
`highly homologous to that of CL and CHI (12), it is reasonable
`to conclude that it shares the basic three dimensional structure
`or immunoglobulin fold of CL and CHI .
`As discussed before (2), the Kern and Oz serological markers
`of human 'A. chains, which correspond to positions 154 and 191
`in the L chain sequence, occur on the surface of the molecule,
`in close spatial proximity. The Inv allotypic markers of human
`K chains have recently been shown (13) to involve Ala/ Val
`and Val/Leu substitutions at positions 153 and 191, respec(cid:173)
`tively, which closely correspond to the positions of the Kern
`and Oz markers in human 'A. chains. Replacements at positions
`153 and 191 in K chains will also affect antigenic determinants
`of the molecule that are recognized by anti-allotypic antisera.
`Since the distance between the a-carbon atoms of the ho(cid:173)
`mologous residues is about 8-10 A, replacements involving
`both positions can be simultaneously recognized by a single
`anti-allotypic antibody molecule.
`Some of the variable and constant features of VL sequences
`can be discussed in terms of the three-dimensional structure
`of Vx New. Hairpin bends in the polypeptide chain of Vx
`New occur around positions 14-15, 27-30, 39-40, 67-68, and
`92- 93 and an approximate 90° bend around residues 75-76.
`Except for the bend at positions 92-93 (a hypervariable re(cid:173)
`gion) all others involve a Gly residue that is constant in
`human 'A. chain sequences. Most of these bends also involve a
`constant or nearly constant Pro-Gly or Ser- or Thr-Gly se(cid:173)
`quence. A similar conclusion has been obtained from the study
`of a crystalline V. fragment (4). Glycine residues also con(cid:173)
`tribute to a constant sequence (Phe-Gly-Gly-Gly, positions 99--
`102) that is not part of a bend. The constant character of
`this sequence in all 'A. chains can be explained by the following
`observations: (a) Phe 99 is located in an internal, interchain
`hydrophobic pocket that includes the homologous constant
`Trp 108 in VH, related to Phe 99 by a local pseudo 2-fold axis
`of symmetry; it can be assumed that Phe 99 (and Trp 108)
`make an interchain contact that is important for VL-VH
`
`assembly; (b) Gly 100 in Vx (or Gly 109 in VH) is tightly
`packed between the intrachain disulfide bond and Leu 4 (a
`constant residue in VL and VH); (c) Gly 101 is relatively close
`to the constant Gin 6, although here there is room for a side
`chain as observed in V. (Gin 101) or in VH (position 110);
`(d) Gly 102 (111 in VH) is very close to a constant aromatic
`residue (Tyr/ Phe, 86 in Vx or 95 in VH) so that the limited
`space available requires the presence of a Gly residue at this
`position. Some other residues that are constant in Vx or that
`show only a limited degree of variability, such a Tyr 35, Gin
`37, Ala 42, Pro 43, and Asp 84 are involved in close contacts
`with the VH subunit. Other constant residues such as Gin :fl
`and Tyr 85, Glu 82 and Tyr 142 (CL) make internal hydrogen
`bonds. In addition to the residues just discussed, most of t_he
`nonpolar, hydrophobic amino acids that occur in the interior
`of the structure between the two /3-sheets are invariant or are
`replaced by other hydrophobic residues. They are Leu 4, Gin
`6, Val 10, Val 18, Ile 20, Cys 22, Val 32, Trp 34, Leu 46, Phe
`61, Val 63, Ala 70, Leu 72, Ile 74, Leu 77, Ala 83, Tyr 85, Cys
`87, Ser 89, Val 98, Thr 103, Leu 105, and Val 107. All the con-
`r con·
`d
`t
`stant or nearly constant residues that appear at ben s O
`tribute to intra- and inter-subunit bonds seem to be importan f
`for the preservation of structure. Mutations that alter anY ; 1
`these residues, which constitute more than 50% of th~t ed
`number of residues of the V x sequence, cannot be cons! er of
`to be "neutral or modulating" (14). Different combinationslJI·
`these invariant and semi-invariant residues that a~ coen·
`patible with the requirements of the constant three ~ ..,
`.
`.
`ur vie .. ,
`gene
`sional structure of the homology subumts are, iil O•
`better explained by a process of evolutionary germ hnet •4
`.

`By con r ..... '
`ari·
`divergence than by random somatic mutations.
`the nature of the residues that occur in the regions of hype:a to
`able sequence, at one end of the molecule and fully expo jnts·
`the solvent, is not limited by any visible structural constra ence
`It has recently been pointed out (15) that the seQ~talli
`Arg/ Lys-Phe-Ser-Gly-Ser-Lys (positions 60-65) is con .-(cid:173)
`in 'A. chains from several animal species that have been
`
`PFIZER EX. 1115
`Page 8
`
`

`

`Nat. Acad. Sci. USA 71 (1974)
`
`Structure of Human Fab' at 2.0 A-Resolution
`
`3443
`
`and that this sequence could, therefore, fulfill a special
`on. The side chains of Phe 61 and Gly 63 (Val 63 in >,.
`) are part of the internal hydrophobic core surrounded
`p-pleated sheets; consequently, they could be replaced
`y other non polar residues. Arg 60 appears to pe involved
`internal hydrogen bond to Glu 80 and/ or Gln 78. How(cid:173)
`the side chains of the other residues of that constant
`ce are external with no apparent structural constraint.
`es that occur in the constant or nearly constant N(cid:173)
`I sequences of Vx, V., and VH can be analyzed in simi-
`ms: some are internal (residues 4, 6, 10, 12 in Vx) and
`not be expected to show much change, but others have
`I side chains with no visible constraints (positions 5, 9,
`16in Vx).
`discussed before (2), tl'ie VH subunit exposes a larger area
`region of the active site. Comparison of the three-dimen-
`model of Fab' New with that of a >.. chain dimer (3)
`V. dimer (4) suggests that the VH subunit plays an
`"al role in defining the conformation and the specificity
`antigen binding site. The VH hypervariable sequences
`· g from positions'50-60 and 100-110 are longer than
`mologous regions of L chains. In particular, the third
`ariable region of V H has been found to consist of a
`e number of amino-acid residues, ranging from 13 to 20
`counted from Cys 96 to Trp 108, whereas the homol(cid:173)
`loop of V x and V. ( Cys 87 to Phe 99) has been found to
`• only 11 to 13 residues. This hypervariable loop of VH
`ot conform to the approximate local 2-fold axis of sym(cid:173)
`relating VL to VH. Instead, this loop bends towards the

`(see Fig. 4), making the structural pocket at the
`site (2, 16) narrower than it is in L chain dimers, where
`rs as a large cavity (3, 4). The width and depth of the
`site pocket of different immunoglobulins can, therefore,
`red by variations in the length of this hypervariable
`p. Thus different H chains that pair with the same L
`in induced antibodies (17) could modulate affinity not
`Y changes in the amino acids present in this sequence
`by alterations in the length of the polypeptide chain
`region.
`ough the length of the L chain hypervariable regions is
`ely constant, some human and mouse (18, 19) K chains
`been found to include additional residues in the first
`ariable region (positions 25-32). This additional length
`ypeptide chain will also have an important effect in
`· ing the dimensions of the active site pocket and the
`specificity of the immunoglobulin molecules to which
`belong.
`h the model of Fab' New as a basic structural frame(cid:173)
`a striking correlation between the structure and func-
`f the well-studied MOPC 315 anti-Dnp mouse myeloma
`(20, 21) can be obtained. The L(>..) chains of IgG

`and MOPC 315 are highly homologous and contain an
`number of residues in the third hypervariable region
`een the constant amino acid residues Cys 89 and Phe 99.
`a comparison of the tentative sequence of VH New (Fig.
`d that of VH MOPC 315 indicates that the third hyper(cid:173)
`ble regions of VH in both chains between the constant
`96 and Trp 108 include the same number of amino acid
`Ues. It is, therefore, feasible to fit the MOPC 315 sequence
`~ the basic VL and VH structures obtained in the 2.0-A
`. er map of Fab' New. The model of the MOPC 315
`g site that emerges from this comparison includes a
`
`Fra. 4. View of some of the amino-acid residues at the active
`site of IgG New. Residue numbers for VL (27 to 31 and 89 to 95)
`and Va correspond to t hose of Fig. 1.
`
`crevice similar to that shown in Fig. 4, in which L chain Tyr 34
`forms the "upper" limit, H chain Trp 47 and Phe 50 form the
`"lower" limit, L chain Phe 99, H chain Tyr 104 and Phe 34
`contribute to the "sides" and L chain Trp 98 and Phe 103 and
`H chain Phe 105 form the 6- to 10-A deep "floor." The high
`density of adjacent aromatic side chains that line this crevice,
`at the center of the active region, is striking and correlates
`with the observed specificity of MOPC IgA irnmunoglobulin
`for Dnp and other haptens that include benzene and naph(cid:173)
`thalene aromatic rings. The relatively shallow depth of the
`active center is in agreement with the electron microscopy
`study of a complex between MOPC 315 IgA and the bifunc(cid:173)
`tional hapten bis(Dnp-{:1-alanyl)-diaminosuccinate (20)
`in
`which the Dnp groups that join the Fab arms of different IgA
`molecules end to end are only 15 A apart.
`The possibility of a conformational change as a biological
`signal triggered py antigen binding is an important question
`to be considered in discussing immunoglobulin structure.
`In this context, the Fab structure can be described as a tetra(cid:173)
`hedral arrangement of homologous subunits, covalently linked
`in pairs (VL to CL and VH to CHI) by linear stretches of poly(cid:173)
`peptid~ chain ("switch" regions) bent to a larger extent in the
`Fd' chain than in the L chain (2), suggesting flexibility.
`Furthermore, two identical L chains of a dimer assume differ(cid:173)
`ent conformations (3), such that one of them appears similar
`to the µ chain of Fab', making an angle greater than 90°
`between the major axes of the CL and VL subunits, whereas the
`other L chain of the dimer makes an angle smaller than 90°,
`as observed between the VH and CHI subunits of Fab' New.
`These observations suggest that a conformational change
`could take place by a hinge-like movement at one or both
`switch regions. Since a disulfide bond linking VL to CL has been
`found in some rabbit IgG molecules (22, 23), the flexibility of
`the more open L chain may be more limited than that of the H
`chain. An "opening" of the Fd' chain, as illustrated in Fig. 5,
`
`PFIZER EX. 1115
`Page 9
`
`

`

`3444
`
`Immunology: Poljak et al.
`
`FIG. 5. A view of the a-carbon backbone of Fab' New. The
`V and C1 domains, the L chain (open line), the Fd' chain (solid
`line) and the local, approximate 2-fold axes (broken lines)
`relating the VL to the Vn subunit and the CL to the Cnl subunit
`are shown. The two short arrows indicate the switch region of
`both chains. The longer arrow indicates a possible relative motion
`of the V and C1 domains (see text).
`
`would lead to a relative movement of the structural subunits
`and to the exposure of some of the VH and CHI side chains that
`were not previously exposed. A relative movement of struc(cid:173)
`tural subunits leading to changes in quaternary structure has
`been demonstrated by crystallographic analyses of reduced
`and oxygenated hemoglobin molecules (24). Although no
`major conformational changes ha¥e been observed after.bind(cid:173)
`ing of ligapds to Fab' fragments (16, 25) the occurrence of
`such changes cannot be ruled out on the basis of these experi(cid:173)
`ments carried out in the crystalline state. Furthermore, some
`of the interactions necessary to trigger the postulated con(cid:173)
`formational change may not be present in the binding of rela(cid:173)
`tively small haptenic groups such as phosphoryl choline (25)
`
`)
`Proc. Nat. Acad. Sci. USA 71 (lB74
`f
`and vitamin K10H (16) which can only interact with som
`e 0
`the side chains of the active site.
`This research was supported by Grants AI 08202 from the
`National Institutes of Health, NP-141A from t he American
`Cancer Society, and N .I.H. Research Career Development
`Awatd AI 70091 to R.J.P.
`
`1. World Health Organization (1964) Bull. W.H.O. 30, 447--450
`2. Poljak, R. J ., Amzel, L. M., Avey, H. P., Chen B L .
`Phizackerley, R. P . & Saul, F. (1973 ) Proc. Nat. A~d." &/,
`USA 70, 3305- 3310.
`3. Schiffer, M., Girling, R. L., Ely, K. R. & Edmundson A B
`'


`(1973) Biochemistry 12, 4620--4631.
`4. Epp, 0 ., Colman, P., Fehlhammer, H., Bode, W., Schiffer
`M . & Huber, R. (1974) Eur. J. Biochem., 45, 513-524.
`'
`5. Poljak, R. J., Amzel, L. M., Avey, H. P ., Becka L. N
`Goldstein, D. J. & Humphrey, R. L. (1971 ) Cozd Sp,;,;;
`Harbor Symp. Quant. Biol. 36, 421-425.
`6. Poljak, R. J ., Amzel, L. M ., Avey, H. P., Becka, L. N. &
`Nisonoff, A. (1972) Nature N ew Biol. 235, 137- 140.
`7. Richards, F . M. (1968) J. Mol. Biol. 37, 225-230.
`8. Chen, B. L. & Poljak, R. J. (1974) Biochemistry 13, 1296-
`1302.
`9. Edelman, G. M., Cunningham, B. A., Gall, W. E., Gottlieb
`P. D., Rutishauser, U. & Waxdal, M . J. (1969) Proc. Nat'.
`Acad. Sci. USA 63, 78- 85.
`10. Dayhoff, M . 0., ed. (1972) Atlas of Amino Acid Sequence
`and Struture, Vol. 5 (National BioMedical Research Foun(cid:173)
`dation, Silver Sprµig, Md.).
`11. Low, B. W. & Grenville-Wells, H.J. (1953) Proc. Nat. Acad.
`Sci. USA 39, 785-801.
`12. Peterson, P . A., Cunningham, B. A., Berggard, I. & Edel(cid:173)
`man, G. M. (1972) Proc. Nat. Acad. Sci. USA 69, 1697-1701.
`13. Milstein, C. P., Steinberg, A. G., McLaughlin, C. L. &
`Solomon, A. (1974) Nature 248, 160--161.
`14. Weigert, M. G., Cesari, I. M ., Yonkovich, S. J. & Cohn, M.
`(1970) Nature 228, 1045-1047.
`15. Stanton, T., Sledge, C., Capra, J. D ., Woods, R., Clem, W.
`& Hood, L. (1974) J. Immunol. 112, 633- 640.
`16. Amzel, L. M., Poljak, R. J., Saul, F., Varga, J. M. &
`Richards, F. F. (1974) Proc. Nat. Acad. Sci. USA 71, 1427-
`1430.
`17. Friedenson, B., Appella, E., Takeda, Y., Roholt, 0. A. &
`Pressman, D . (1973) J. Biol. Chem. 248, 7073-7079.
`18. McKean, D ., Potter, M . & Hood, L. (1973 ) 8iochemistry 12,
`760--771.
`19. Barstad, P., Rudikoff, S., Potter, M ., Cohn, M., Konigsberg,
`x E.
`W. & Hood, L. (1974) Science 183, 962-964.
`20. Green, N. M ., Dourmashkin, R. R. & Parkshouse, R. l\,.
`. H N
`(1971) J. Mol. Biol. 56, 203-206.
`21. Francis, S. H ., Leslie, R. G. Q., Hood, L. & EIBen,


`Nol
`(1974) Proc. N at. Acad. Sci. USA 71, 1123-1127.
`22. Poulsen, K., Fraser, K . J. & Haber, E. (1972) Proc.

`S3
`Acad. Sci. USA 69, 2495- 2499.
`23. Appella, E. (1973) Biochem. Biophys. Res. Commun.
`'
`L C
`1122- 1129.
`24. Perutz, M. F., Muirhead, H., Cox, J. M. & Goaman,


`. D R.
`G. (1968) Nature 219, 131- 139.
`1 245;
`25. Padlan, E. A., Segal, D. M., Spande, T. F ., Davies?
`Rudikoff, S. & Potter, M . (1973 ) Nature New Bio·
`165-167.
`
`PFIZER EX. 1115
`Page 10
`
`

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket